The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib combined with penpulimab and nab-paclitaxel as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial.
 
Zhiwei Chang
No Relationships to Disclose
 
Xiao-Lei Liu
No Relationships to Disclose
 
Dan-Dan Yu
No Relationships to Disclose
 
Hui-Qiong Han
No Relationships to Disclose
 
Jian He
No Relationships to Disclose
 
Rui-Rui Wang
No Relationships to Disclose
 
Yan-ru Qin
No Relationships to Disclose